16-09-2024, 17:05

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
Globe Newswire16-09-2024, 17:05
5-02-2024, 16:00

Blue California completes groundbreaking human clinical trial on ErgoActive® ergothioneine intervention for cognitive function, memory, and sleep
Globe Newswire5-02-2024, 16:00